CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Is a Beat in the Cards for CVS Health (CVS) in Q4 Earnings?
by Zacks Equity Research
Through November and December, the resurgence of new COVID-19 cases might have resulted in more COVID-19 tests conducts by CVS Health (CVS).
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $73.49, moving +0.7% from the previous trading session.
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.24 in the latest trading session, marking a +1.96% move from the prior day.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $72.61, marking a +0.26% move from the previous day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $74.08, marking a -1.55% move from the previous day.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $75.05, moving +0.17% from the previous trading session.
The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health
Top Analyst Reports for Amazon, Thermo Fisher & Eli Lilly
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Thermo Fisher Scientific (TMO), and Eli Lilly (LLY).
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.99 in the latest trading session, marking a +1.97% move from the prior day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $68.30, marking a +0.81% move from the previous day.
CVS Health's (CVS) Front Store Sales Robust, LTC Suffers
by Zacks Equity Research
CVS Health's (CVS) Health Care Benefits arm benefits from strong Medicare annual enrollment period.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $68.01, marking a +1.18% move from the previous day.
Magellan Health (MGLN) Buys Bayless to Aid Behavioral Health
by Zacks Equity Research
Magellan Health (MGLN) purchases a majority stake in Bayless Integrated Healthcare to bolster/evolve its collaborative care strategy.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $69.54 in the latest trading session, marking a +0.32% move from the prior day.
The Zacks Analyst Blog Highlights: Cisco Systems, CVS Health, Moderna, Pfizer and Hilton Worldwide
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cisco Systems, CVS Health, Moderna, Pfizer and Hilton Worldwide
CVS Health (CVS) 2021 Selling Season Strong, LTC Arm Suffers
by Zacks Equity Research
Since the start of the pandemic, CVS Health (CVS) is seeing more than 40% of all specialty orders being placed digitally.
CVS Health (CVS) Up 21.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Analyst Reports for Cisco, CVS Health & Moderna
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), CVS Health Corporation (CVS) and Moderna, Inc. (MRNA).
Amazon (AMZN) Ups Pharmacy Retail Game With New Online Store
by Zacks Equity Research
Amazon (AMZN) unveils Amazon Pharmacy, the new online store for prescription medicines. This is likely to drive its customer momentum amid the pandemic.
Markets Roll Back from All-Time Highs: WBA, WMT, KBH & More
by Mark Vickery
This is the first down close in the last three sessions for the main indexes, which were once again outpaced by the small-cap Russell 2000.
CVS Health Prescription Volume Solid, Price Cut Woes Stay
by Zacks Equity Research
CVS Health's (CVS) consumer centric digital strategy is even more relevant amid the pandemic.
Company News for Nov 9, 2020
by Zacks Equity Research
Companies In The News Are: COTY, HSY,, MAR, CVS
CVS Health (CVS) Q3 Earnings Top Estimates, 2020 View Up
by Zacks Equity Research
CVS Health's (CVS) Q3 pharmacy claims processed rise attributable to strong net new business, partially offset by reduced new therapy prescriptions.